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Available online 23 October 2015Calophyllum brasiliense (Calophyllaceae) is a tropical rain forest tree, mainly distributed in South and Central
America. It is an important source of bioactive natural products like, for instance soulatrolide, and mammea type
coumarins. Soulatrolide is a tetracyclic dipyranocoumarins and a potent inhibitor of HIV-1 reverse transcriptase
andMycobacterium tuberculosis. MammeaA/BA andA/BB coumarins, pure or as amixture, are highly active against
several leukemia cell lines, Trypanosoma cruzi and Leishmania amazonensis. In the present work, a toxicogenomic
analysis of Soulatrolide and Mammea A/BA + A/BB (3:1) mixture was performed in order to validate the toxico-
logical potential of this type of compounds. Soulatrolide or mixture of mammea A/BA + A/BB (3:1) was adminis-
tered orally to malemice (CD-1) at dose of 100 mg/kg/daily, for 1 week. After this time, mice were sacriﬁced, and
RNA extracted from the liver of treated animals. Transcriptomic analysis was performed using Affymetrix Mouse
Gene 1.0 ST Array. Robust microarray analysis (RMA) and two way ANOVA test revealed for mammea mixture
treatment 46 genes upregulated and 72 downregulated genes; meanwhile, for soulatrolide 665 were upregulated
and 1077 downregulated genes. Enrichment analysis for such genes revealed that in both type of treatments ge-
netic expressionweremainly involved in drugmetabolism. Overall results indicate a safety proﬁle. Themicroarray
data complies with MIAME guidelines and are deposited in GEO under accession number GSE72755.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).(SpeciﬁcationsCubject area Chemistry
ore speciﬁc subject area Natural Products–Toxicogenomics
rganism/cell line/tissue CD-1 mice
x Male
quencer or array type Affymetrix mouse gene chip 1.0 ArraySaata format Raw and Analyzed with RMA and two way ANOVA
xperimental factors Comparison of control (SSI) and treatment
(100 mg/Kg) with soulatrolide or mammea
A/BA + A/BB (3:1) mixturexperimental features RNA was extracted from the liver of mice after 1 week
of treatment, converted to cDNA and hybridized to
Affymetrix arrays(J.C. Gomez-Verjan),
. This is an open access article under thcontinued)
SpeciﬁcationseonsentCC BY-NC-ND license (httpAll animal work was conducted in strict accordance with
relevant national and international guidelines. The study
protocol IG-2005-13 was approved by the Animal and
Ethics Experiment Board of School of Medicine of
Universidad Nacional Autónoma de Méxicomple source location Facultad de Medicina, Universidad Nacional
Autónoma de Mexico, Mexico City, Mexico.1. Direct link to deposited data
The data is deposited in GEO under accession number GSE72755:
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72755.
2. Value of the data
- The data provide a toxicogenomics signature of two types of phar-
macological active coumarins that could be for comparison in
other studies of this kind.://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Analysis of pathways enriched by coumarins treatments (Soulatrolide 1744 DEG's and Mammea A/BA + A/BB-120 DEG's).
Treatment/genes Pathway P-Value Count
Mammea A/BA + A/BB (3:1)
Down Regulated Genes
(Fold Change N1.5 b−1.5; p-value b0.05).
KEGG_PATHWAY:
00830 Retinol metabolism
4.96E-5 8
KEGG_PATHWAY:
00982
Drug metabolism
0.00103 5
Mammea A/BA + A/BB (3:1)
Up regulated genes
(fold change N1.5 b−1.5; P-VALUE b0.05).
KEGG_PATHWAY
04060:Cytokine–cytokine
receptor interaction
0.005272 4
Soulatrolide
Down regulated genes
(fold change N1.5 b−1.5; p-value b0.05).
KEGG_PATHWAY
00980:Metabolism of xenobiotics by cytochrome P450
3.36E-11 34
KEGG_PATHWAY
00982:Drug metabolism
4.94E-10 38
KEGG_PATHWAY
00830:Retinol metabolism
2.36E-8 52
Soulatrolide
Up regulated genes
(Fold change N1.5 b−1.5; p-value b0.05).
KEGG_PATHWAY
00980:Metabolism of
xenobiotics by CYP
P450
3.359E-11 34
KEGG_PATHWAY
00982:Drug
metabolism
4.94E-10 38
KEGG_PATHWAY
00830:Retinol
metabolism
2.36E-8 52
259J.C. Gomez-Verjan et al. / Genomics Data 6 (2015) 258–259- The data provide an insight in the metabolism induced by pharma-
cological active coumarins.
- This data provides theﬁrst toxicogenomic analysis onmammea type
coumarins particularly mammea A/BA and A/BB, and on tetracyclic
coumarins such as soulatrolide.3. Experimental design, materials and methods
3.1. Toxicogenomics assay
A total of 12 male mice (Mus musculus) strain CD1 (Charles River),
body weight 25 ± 4 g, with an age of two month old, were provided
by the School of Medicine of the National University of Mexico
(UNAM). The animals were kept under standard conditions in ventilat-
ed boxes (12 h light/dark and 27±2 °C) and fedwith RatChow™ divid-
ed in three groups depending on treatments: 1)Soulatrolide,
2)Mammea (A/BA + A/BB 3:1) and 3) Isotonic Saline Solution 0.9%
(control). Treatments were administered orally for 7 days at a dose of
100 mg/Kg/daily [1]. All animal work was conducted in strict accor-
dance with relevant national and international guidelines. The study
protocol IG-2005-13 was approved by the Animal and Ethics Experi-
ment Board of School of Medicine of Universidad Nacional Autónoma
de México. Liver of animals was immediately obtained after sacriﬁced
and samples immediately homogenized with PureLink® RNA Mini
Kit.The amount of RNA was determined by using Nanodrop®2000
(ThermoScientiﬁc, Waltham, MA, USA), integrity of RNA was deter-
mined using a Bioanalyzer®(Agilent, Waldbronn, Germany) cDNA syn-
thesis, target hybridization, probe array washing, staining and
subsequent probe array scanning were done according to the standard
protocol 3′IVT Express Kit User Manual (Affymetrix). Microarray analy-
sis was performed by using Affymetrix Mouse Gene Chip 1.0 Array,
using three microarrays per treatment.
3.2. Microarray experiments and data acquisition processing
Signal intensities from each array were analyzed using Partek
Genomic Suite 6.4 (Partek Inc., Missouri, USA). Raw intensity probevalues were normalized using robust multiarray analysis background
correction (RMA). A two way ANOVA was performed to identify differ-
entially expressed genes. Only genes with statistically signiﬁcant differ-
ences in expression levels (p-value b 0.05) and a fold change criteria of
≥1.5and ≤−1.5 were included in the ﬁnal set of differentially expressed
genes (Table 1).
3.3. Gene ontology (GO) analysis
The list of genes with signiﬁcantly changed expression levels for
both treatments revealed 46 genes up and 72 downregulated genes;
meanwhile, for soulatrolide 665 up and 1077 downregulated genes
were used as input lists for the DAVID Functional Annotation Clustering
tool [2]. This open source software provides an enrichment analysis of
annotation and gene ontology terms based on a GO: TermFinder. The
corrected p-value was obtained by applying Bonferroni correction [2].
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